
    
      Primary Objectives:

      1. To determine the safety and feasibility of anti- MESO CAR-T cells therapy for
      Refractory-Relapsed Ovarian Cancer

      Secondary Objectives:

        1. To access the efficacy of anti- MESO CAR-T cells in patients with ovarian cancer.

        2. To determine in vivo dynamics and persistency of anti- MESO CAR-T cells

        3. To assess the quality of life in patients with ovarian cancer after treatment with anti-
           MESO CAR-T cells.
    
  